Drug‐induced hypersensitivity syndrome (DIHS) is a type of severe cutaneous adverse reaction (SCAR). DIHS typically occurs 2–6 weeks after initiation of the offending medication. We report a case of DIHS… Click to show full abstract
Drug‐induced hypersensitivity syndrome (DIHS) is a type of severe cutaneous adverse reaction (SCAR). DIHS typically occurs 2–6 weeks after initiation of the offending medication. We report a case of DIHS in a pediatric patient undergoing treatment of metastatic melanoma with nivolumab and ipilimumab.
Keywords:
drug induced;
hypersensitivity syndrome;
pediatric patient;
drug;
induced hypersensitivity;
nivolumab ipilimumab
Journal Title: Pediatric Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatric Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!